Entity Common Stock, Shares Outstanding of NYMOX PHARMACEUTICAL CORP from 31 Dec 2017 to 31 Dec 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NYMOX PHARMACEUTICAL CORP quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2024.
  • NYMOX PHARMACEUTICAL CORP Entity Common Stock, Shares Outstanding for the quarter ending 31 Dec 2024 was 94,540,140, a 1.1% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

NYMOX PHARMACEUTICAL CORP Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 94,540,140 +1,000,000 +1.1% 31 Dec 2024 20-F 03 Jun 2025 2024 FY
Q4 2023 93,540,140 +3,025,000 +3.3% 31 Dec 2023 20-F 29 Aug 2024 2023 FY
Q4 2022 90,515,140 +4,969,265 +5.8% 31 Dec 2022 20-F 02 May 2023 2022 FY
Q4 2021 85,545,875 +7,584,724 +9.7% 31 Dec 2021 20-F 30 Mar 2022 2021 FY
Q4 2020 77,961,151 +6,742,445 +9.5% 31 Dec 2020 20-F 29 Mar 2021 2020 FY
Q4 2019 71,218,706 +6,542,450 +10% 31 Dec 2019 20-F 30 Mar 2020 2019 FY
Q1 2019 0 0 31 Mar 2019 6-K 15 May 2019 2019 Q1
Q4 2018 64,676,256 +8,297,950 +15% 31 Dec 2018 20-F 29 Mar 2019 2018 FY
Q3 2018 0 13 Nov 2018 6-K 13 Nov 2018 2018 Q3
Q2 2018 0 09 Aug 2018 6-K 13 Aug 2018 2018 Q2
Q1 2018 0 15 May 2018 6-K 15 May 2018 2018 Q1
Q4 2017 56,378,306 31 Dec 2017 20-F 30 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.